Newsletter | September 22, 2025

09.22.25 -- Did Trump Just Create An Antibiotic Supply Chain In The US?

SPONSOR

Explore 20+ new CDMO presenters in quick 20-minute sessions during Outsourced Pharma’s October Partner Week. Sessions include Analytical Services, ADC, Large and Small Molecules, Cell and Gene Therapy, and Fill/Finish. Each session offers a quick, informative look at capabilities to help you find the best-fit partner. Registration, on-demand access, and interactive Q&A are all free.

INDUSTRY INSIGHTS

Understanding And Mitigating Oxygen Heterogeneity In Large-Scale Bioreactors

Oxygen heterogeneity, caused by pressure variations and other factors in large-scale bioreactors, can significantly impact cell growth and product yield.

Getting To The Heart Of CDMO Tech Transfer Excellence

Discover five key factors for seamless, efficient technology transfer — and why technical expertise, customer focus, and operational flexibility are vital to CDMO success.

Switching From Vials To PFS And Intravenous To Subcutaneous Formulations

Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.

FEATURED EDITORIAL

Did Trump Just Create An Antibiotic Supply Chain In The US?

In 2022, we had headlines such as: FDA Declares Nationwide Amoxicillin Shortage. Now three years later a homegrown manufacturer — USAntibiotics of Bristol, Tennessee — says it can cover America’s demand under a new arrangement with two titans of distribution and retail: McKesson and Walmart. The other “titan” in the deal is President Trump.

What Biotech Sponsors Should Look For In A CDMO For Sterile Fill/Finish

Choosing the right CDMO partner for a biotech product isn’t about “capacity at a good price”; it’s about a partner with the right mix of technical expertise, regulatory track record, and more.

INDUSTRY INSIGHTS CONTINUED

A Smarter Workforce Strategy

Witness how compliant, on-site scientific staffing ensures continuity, reduces HR burden, avoids co-employment risks, and outperforms temporary staffing in retention, savings, and efficiency.

What You Paste Matters

Explore the use of transposase/transposon systems in the biotech industry, particularly in the development of stable cell lines for protein manufacturing.

Driving Operational Excellence Using Machine Learning

Using a case study on afucosylated glycan levels, we highlight the impact of data-driven methodologies on improving process outcomes and ensuring the highest standards of quality and reliability.

De-Risking A Bioconjugate's Development Path From Discovery To Clinic

Understanding the obstacles you may face during bioconjugate development, as well as the tools available to help overcome them, can help streamline your product’s path to market.

Prioritizing Data Security Through Digital Transformation

Integrating advanced digitalization solutions and prioritizing data security can accelerate drug development while reducing costs and ensuring consistency across a global network.

SOLUTIONS

Flexible Manufacturing Solutions, Services To Meet Evolving Industry Needs

Review our full range of support services to streamline manufacturing processes through to the commercialization of aseptic and lyophilized products.

Capacity Update April 2025: Fill/Finish

Support your product from development to commercialization with our proven sterile fill-finish expertise, high-potency capabilities, and customizable cleanrooms.

Advance Your Oncology Research With Discovery Services

Find discovery oncology solutions that consist of in vitro assessments, in vivo pharmacology services, in vivo imaging technologies and focal radiation capabilities to support your oncology research programs.

OPCU April 2025: Fill/Finish

Backed by years of dedication to customer-focused solutions, we’re proud to introduce our specialists to the global biopharma community and share insights that drive innovation forward.

OUTSOURCED PHARMA CAPACITY UPDATE

Find Your New CDMO At Outsourced Pharma Capacity Update

CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capacities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs.

Connect With Outsourced Pharma: